This article is an erratum on:
Corrigendum: Prognostic Values and Clinical Significance of S100 Family Member’s Individualized mRNA Expression in Pancreatic Adenocarcinoma
Frontiers Production Officeby Li X, Qiu N and Li Q (2022). Front. Genet. 12:838600. doi: 10.3389/fgene.2021.838600
Due to a production error, the corrections requested in the Corrigendum were not implemented in the original article. Furthermore, the title of the original article was listed as “Pinocembrin Decreases Ventricular Fibrillation Susceptibility in a Rat Model of Depression,” but should have been “Prognostic Values and Clinical Significance of S100 Family Member’s Individualized mRNA Expression in Pancreatic Adenocarcinoma.”
The publisher apologizes for this mistake. The original version of this article, as well as the original article, have been updated.
Keywords: mRNA expression, S100 family, pancreatic cancer, biomarker, prognosis
Citation: Frontiers Production Office (2022) Erratum: Corrigendum: Prognostic values and clinical significance of S100 family member’s individualized mRNA expression in pancreatic adenocarcinoma. Front. Genet. 13:1089027. doi: 10.3389/fgene.2022.1089027
Received: 03 November 2022; Accepted: 03 November 2022;
Published: 18 November 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, production.office@frontiersin.org